821791-58-6

Basic information

• Product Name: 4-CHLORO-1-METHYL-6-OXO-1,6-DIHYDRO-PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER
• Synonyms: ethyl 4-chloro-1,6-dihydro-1-Methyl-6-oxopyridine-3-carboxylate;3-Pyridinecarboxylicacid, 4-chloro-1,6-dihydro-1-Methyl-6-oxo-, ethyl ester;4-CHLORO-1-METHYL-6-OXO-1,6-DIHYDRO-PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER;ETHYL 4-CHLORO-1-METHYL-6-OXO-1,6-DIHYDROPYRIDINE-3-CARBOXYLATE
• CAS NO: 821791-58-6
• Molecular Formula: C₉H₁₀ClNO₃
• Molecular Weight: 215.63
• Mol File: 821791-58-6.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 302.366°C at 760 mmHg
• Flash Point: 136.666°C
• Appearance: /
• Density: 1.316g/cm³
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.544
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: -3.05±0.62(Predicted)
• CAS DataBase Reference: 4-CHLORO-1-METHYL-6-OXO-1,6-DIHYDRO-PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-CHLORO-1-METHYL-6-OXO-1,6-DIHYDRO-PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER(821791-58-6)
• EPA Substance Registry System: 4-CHLORO-1-METHYL-6-OXO-1,6-DIHYDRO-PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER(821791-58-6)

Safety Data

• Hazardous Substances Data: 821791-58-6(Hazardous Substances Data)

Usage

General Description

4-chloro-1-methyl-6-oxo-1,6-dihydro-pyridine-3-carboxylic Acid Ethyl Ester is a specialized chemical compound, often used in the field of organic chemistry. The structure of this compound features a pyridine ring, which is a six-membered ring compound containing nitrogen, and it also includes ethyl ester functionality, a chlorine atom, and a methyl group. As an ester, it has potential uses in various chemical reactions, including synthesis, as esters often serve as intermediates in the production of other chemicals. It's also possible that it could be used as a reagent to introduce the 4-chloro-1-methyl-6-oxo-1,6-dihydro-pyridine-3-carboxylate group into other molecules. The exact properties such as toxicity, reactivity, and applications of this chemical would depend on further scientific testing and study.

InChI:InChI=1/C9H10ClNO3/c1-3-14-9(13)6-5-11(2)8(12)4-7(6)10/h4-5H,3H2,1-2H3

Upstream product

• 853105-37-0 ethyl 4-hydroxy-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate 
• 40296-46-6 ethyl 4,6-dichloronicotinate 
• 77-78-1 dimethyl sulfate 
• 105-50-0 diethyl 1,3-acetonedicarboxylate 
• 74-88-4 methyl iodide 

Downstream Products

• 821791-59-7 4-chloro-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid 
• 853105-72-3 ethyl 4,5-dichloro-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate 
• 914358-80-8 ethyl 4-chloro-5-fluoro-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate 
• 821791-44-0 4-(4-bromo-2-fluorophenylamino)-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid 
• 853105-98-3 4-(4-bromo-2-fluorophenylamino)-5-fluoro-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid 
• 853105-80-3 4-(4-Bromo-2-fluorophenylamino)-5-chloro-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid 
• 853105-54-1 4-(4-bromo-2-fluorophenylamino)-1-methyl-6-oxo-N-(2-(vinyloxy)ethoxy)-1,6-dihydropyridine-3-carboxamide 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AND USES THEREOF

Provided herein are novel heterocyclic compounds, for example, compounds having Formula I, I-P, II, lI-P, or III. Also provided herein are pharmaceutical compositions comprising the compounds and methods of using the same, for example, in inhibiting aldehyde dehydrogenases and/or for treating various cancers, cancer metastasis, type 2 diabetes, pulmonary arterial hypertension (PAH) or neointimal hyperplasia (NIH).

4-Anilino-5-carboxamido-2-pyridone derivatives as noncompetitive inhibitors of mitogen-activated protein kinase kinase

A new series of MEK1 inhibitors, the 4-anilino-5-carboxamido-2-pyridones, were designed and synthesized using a combination of medicinal chemistry, computational chemistry, and structural elucidation. The effect of variation in the carboxamide side chain,

5-SUBSTITUTED-4-`(SUBSTITUTED PHENYL)!AMINO!-2-PYRIDONE DEVIATIVES FOR USE AS MEK INHIBITORS

The present invention relates to 5-substituted-4-(substituted) phenylamino-2-pyridone derivatives of formula (I), pharmaceutical compositions and methods of use thereof as MEK inhibitors. Formula (I) wherein W is formula (II), formula (III), formula (IV),